text:
Thousands of visitors are expected to pack out the streets of Newport for this Saturday's food festival – sponsored by Tiny Rebel.
The award-winning brewery which runs Urban Tap in the city centre is the headline sponsor of the free, one-day event which will see 80 stalls and more than a dozen food demonstrations or talks.
Tiny Rebel's Bradley Cummings said: "We're a proud Newport business so coming on board as headline sponsor of the festival is a great honour."
The Golden Lion at Magor is a supporting sponsor – and two of its chefs are on the bill.
The mouth-watering line-up of chefs includes the Celtic Manor Resort's TV chef Larkin Cen, Ben Periam of Mojo The Food Bar, James Sommerin of The Esplanade in Penarth, and Steve White of The Ruperra Arms.
The festival's hotly-contested teen chef competition final will be staged at 10am upstairs in Newport Market, and there will be a battle of the burgers there between Pretentious Burger Kitchen and Meat Bar & Grill at 4pm.
There's also a packed programme of entertainment with choirs and bands performing throughout the day.
Here are 9 tasty things to do at the festival:
- Learn how to make perfect pasta – including a simple dish anyone can replicate at home – with the Executive Chef of The Park Michelin-starred restaurant and The Brasserie at Lucknam Park Hotel & Spa, Hywel Jones. His session will take place at 11am in the upper area of Newport Market.
- Spice up your life with a tasting of some of the hot and fiery sauces from Monmouthshire producers Sorai. If you love chillis, these sauces are for you! We recommend the onion and balsamic sauce which has a hot tang.
- Brush up on your cake decorating skills at a demonstration with Nia Thomas in 44 High Street at 2pm. Nia has 18 years of experience in decoration and sugar craft – and she has passed on her skills in classes and day schools for the past two years.
- Sample fantastic, fresh, and funky vegetarian food at the Parsnipship stall – created at their base in South Wales. We're in love with Parsnipship's haloumi burgers.
- Catch a demonstration by Gwent chef James Sommerin, whose Penarth restaurant has been awarded title of Best in Wales in the Good Food Guide 2016. He'll be at the Pobl offices at 11.30am. He has inspired his 17-year-old daughter to work alongside him in his kitchen.
- Check out the sweet taste of Clam's Handmade Cakes at their stall – last year, they did a roaring trade. So pop along early to get the widest selection of cakes!
- Learn how to cook with beer with the help of Tiny Rebel's Paul Turley. His demonstration will be in the Pobl offices at 2.30pm.
- Taste some wine or liqueur from exhibitors Cwm Deri Vineyard. We caught up with them at the recent Abergavenny Food Festival and loved their light and bright elderflower gin and smooth sloe gin.
- Grab an ice lolly with a kick from Mojo The Food Bar's pop-up cocktail bar – or a special cocktail created by mixologist and head bartender, Andrej Madaras.
See the full programme of chef demonstrations here: http://www.newportfoodfestival.co.uk/blog/?page_id=3293
The 80 exhibitors are:
Ally's Confectionery
Big G's Grill
Black Mountain Smokery
Ciao Bella
Claire's Kitchen
Dinky Donuts
Ffwrnes Pizza
Flour'd Up
Fresh As A Daisy
Huckleberry Treats
Jayne's Bakes
Med Foods Ltd
MoJo The Food Bar and Dog 'n' Dough
Mr & Mrs Olives
Mr Croquewich (Creative Kitchen)
Noodles In A Box
Senior Twister
Tasty Bites
The Welsh Confectionary
Urban Jungle Coffee


text:
New Kia Cars For Sale in Poughkeepsie NY
Since 1994, Kia has been a recognized vehicle brand known for affordability and reliability. Today, Dutchess Kia has a vast inventory of cars made for commuters & folks looking to save gas, SUVs designed to give you more room & versatility to drive anywhere in the Hudson Valley and minivans designed for large families to be safe & entertained.
Kia Vehicles Near Fishkill & Hyde Park NY
Kia Carnival | Kia Forte | Kia K5 | Kia Niro | Kia Rio | Kia Seltos | Kia Sorento | Kia Soul | Kia Sportage | Kia Stinger | Kia Telluride
By scrolling above, you can see our full new car inventory and see which models we currently have in stock. If one or more catches your eye, feel free to click through and see all the details including the price, color and features offered.
Dutchess Kia will help you find the right vehicle to fit your specific driving needs and budget. We'll also work with you to get the financing or lease that you desire, so you can enjoy your new Kia! Contact our team today to learn even more about any of the vehicles above or to schedule a test drive at our dealership located on Route 9 in Poughkeepsie.

subset: commoncrawl


text:
Berlage, Hendrik Petrus
Berlage, Hendrik Petrus hĕn´drək pā´trüs berlä´gə [key], 1856–1934, Dutch architect. In both his writings and architectural practice, Berlage advocated a return to simplicity of form and clarity of structure. In his Amsterdam Stock Exchange (1898–1903) and the Diamond Workers' Union Bldg. (Amsterdam, 1899–1900), he introduced a flat wall surface within a Romanesque framework suggestive of the works of H. H. Richardson. Berlage took part in city planning projects for the Hague (1908) and Amsterdam (1915). His publications, e.g., Gedanken über den Stil in der Baukunst (1905), won his ideas great favor with the rising generation of modern architects, including the Amsterdam school and the architects of de Stijl.
The Columbia Electronic Encyclopedia, 6th ed. Copyright © 2023, Columbia University Press. All rights reserved.
See more Encyclopedia articles on: Architecture: Biographies


text:
Thursday January 18th Pambazos
Post date: Jan 14, 2018 9:48:07 AM
Pambazo (know at the Webrepublic as the Mexican orange burger) is a dish very similar to the torta or panino made with bread dipped in a red guajillo pepper sauce and filled with papas con chorizo (potatoes with chorizo), served with lettuce, cream, cheese and sauce.
The pambazo bread got his name from the pan basso or low class bread from Mexico's viceregal period. During that period, there were bakeries in Mexico dedicated solely to this type of bread named 'panbasserias' (pambacerías).
Recommended serving: 1 to 3
Price: 8 CHF per piece
Order till: Tuesday January 16th
Delivery: Thursday January 18th


text:
This driving but relaxed piece by BrownHouseMedia will transform your audience's mind. It will lead your clients down a path of hope, confidence and success. This up-beat underscore is the gentle push in the right direction. It will subtly elevate the mood and momentum of your project, ad, or conference.
Multiple commercial edits are included with this track:
- Full Length
- :60 Second (4:50)
- :30 Second (5:52)


text:
Champion Cattle Company - A Study in Efficiency and Market Savvy
Published on Fri, 05/08/2009 - 11:58am
However, critical to this was their ability to eliminate the many uncertainties in their stocker/finishing operation. Efficient, low cost weight gain is paramount at Champion.
In November 2003, Shepherd and Blackburn conceived this vision while visiting a feedlot in Kansas where cattle that Shepherd had backgrounded were being finished. The two returned to North Carolina with the goal of expanding Shepherd's backgrounding/stocker facility into a 1,000-head operation sending cattle to feedlots in the Midwest by the end of 2004 through a retained-ownership structure. After a few years of buying cattle and either shipping them to the Midwest or purchasing from local Midwestern beef producers, it became clear to the tandem that if they were going to be profitable, they needed to get their finishing done closer to where they purchased cattle.
"In 2006 we brought our feeding operation a little closer to the east coast and added backgrounding farms in Virginia and feedlots in Pennsylvania to our program," Blackburn says. This move was made primarily because of the high cost of transporting cattle from the east coast to the feeders in the Midwest. They decided that since the majority of the cattle they purchase are from Virginia and the Carolinas it would make better economic sense to finish them closer to the point of purchase. "We can bring cattle from the Virginia area where we purchase a lot of cattle and unload them here with our feeder cattle," he outlines, "and turn right around and load those same trucks with cattle we have just backgrounded and ship them right back to the finish yard in Pennsylvania. This keeps our trucks rolling and full."
"We still purchase a lot of cattle in the Midwest," Shepherd adds, "but rather than ship them all the way to NC, we're working with a local partner in the Midwest who is preconditioning our cattle there and sending them to the feed lots out there. It keeps us diversified and cuts our transportation costs significantly."
Cattle arrive at one of Champion's locations usually within twenty-four hours of purchase and are provided with clean water and fresh leafy hay. "We allow cattle a minimum of 24 hours to fill up on water and hay before their initial processing," adds Farm Manager Seth Church who joined Champion Cattle Company in May of 2004. Church, an Agricultural Business Management graduate of North Carolina State University, says eliminating stress on these incoming calves is paramount to the quality of animal they produce and sell.
And stress is something Champion's management and employees don't tolerate. "Stress is a factor we take great consideration in keeping to a minimum because it is scientifically proven to be a major factor in Bovine Respiratory Disease (BRD)," notes Church. Processing facilities that allow cattle to flow easily through pens and working chutes is a critical aspect in low stress handling.
"And there is nothing more stressful than flies," Shepherd stresses. "We have a huge fly problem. We see significant weight losses when we don't have a good fly control program in place. Also, from a sanitary standpoint around our starter barns, we have to keep fly pressure under control. We looked at and used a lot of insecticide ear tags, but we really like the 40% diazinon-based Patriot insecticide cattle ear tags. We also use them in our grazing program when we turn cattle out on grass and in our feedlot program. We also incorporate Permectrin CDS around our barns to keep fly pressures under control as well. The cowboys really like that they don't have to fight flies when they're working cattle."
And yes, they rotate tags to keep resistance under control, emphasizes Church. "Fly tags have been a part of our fly control program since Champion Cattle Company was formed. It is by far the most economical way to keep flies under control. We tag the animals and pretty much leave them to eat and grow.
"From a labor and economics standpoint," Church claims, "insecticide ear tags makes total sense for us. In today's cattle market, a pound of gain on a calf is worth at least $1.00/lb., if not more. That means we're making at least $15 to $20 per calf by having good fly control. That's a no-brainer in today's cattle market."
Because of their location, Church starts tagging in early April. "These cattle are tagged with the Patriot tag and then those cattle won't be caught again until late summer. That is why we use the Patriot tag because we don't worry about the tag not providing good control during the time period. However, with resistance always a concern, we're looking at extending the control and staving off resistance with the rotation to Avenger ear tags this season. We haven't used them yet; however, we have seen the data and it is impressive, especially for the length of the season we have to have fly control."
According to Blackburn, "We let the market dictate the type of cattle we buy." For instance, they can buy the weight cheaper than they can put it on right now, so that's what they're doing. Champion is structured to bend and flow with the markets and the customer's demands. "When corn was $2/bushel, we could put it on cheaper than buying the weight. But with the current price of corn, we can buy the weight cheaper," Blackburn notes. Currently they're buying six-weight cattle and finishing those types of cattle.
In the summer of 2006, a computer system with management software to help in tracking the movement of cattle was installed. "This system allows them to monitor expenses associated with individual lots of cattle," says Church. "We have found keeping records on the back of an envelope may not always provide us with all the details needed. The record keeping we do is as important to our bottom line as keeping the cattle inside the fence."
And as the incoming President (2010-2011) of the North Carolina Cattlemen's Association, taking the stress off of the cow/calf producer fits perfectly into Shepard's future plans. "The foundation and future to value-added beef products for consumers starts and ends with the cow/calf producer," Shepherd states. "If we can't help make this segment of the beef business profitable, then producers like us who are in the feeder calf business will be out of business pretty quickly. This in turn hurts the feed companies and the entire food chain. It's a daunting task that we take very seriously. We have to do something now, not 10 years from now."
Shepherd, Blackburn, and Church strive to produce "quality pounds of beef" with reasonable profitability. The trio attributes their success to the diligence used when purchasing quality animals to introduce to the program, well-managed nutrition and effective animal health programs, and utilizing strategic marketing options.
Looks like the industry is in good hands.


text:
- Industries
- Aerospace
- Automotive
- Chemicals & Refining
- Construction
- Electronics
- Environment
- Fish Farming
- Food & Beverages
- Glass
- Healthcare
- Laboratories
- Metal Fabrication
- Offshore
- Pharma & Biotechnology
- Power & Energy
- Pulp & Paper
- Restaurants & Bars
- Plastics & Rubber
- Ship Building
- Steel & Metals
- Transportation & Logistics
- Water and Wastewater Treatment
The food industry is facing tougher challenges, as consumers demand higher quality and more variety. We work closely with food and beverage customers around the world, to deliver gas solutions that improve product quality, lower production costs and increase competitiveness.
Beer, soft drinks and sparkling water is a part of our daily lives. Gas technology has always played a key role in the development and production of these beverages. Gases are used by all players in the beverage industry, from large bottling plants to small bars and restaurants.
We also offer technical support and innovative solutions for the processing and packaging of bakery and dairy products, poultry, red meat, seafood, fruit, vegetables and processed products.
Ingredient preparation – cryogenic crystallization for instant production of powder for liquid fat-based ingredients used in bakery, dairy and confectionery products
Mixing, blending, conveying and tumbling:
Bottom injection systems for rapid chilling during mixing and blending operations, with uniform temperature distribution and batch-to-batch consistency
Snow horns for precise, high-performance processing of perishables
Carbon dioxide and nitrogen-chilled vacuum tumbling systems to reduce processing time and improve product quality
Controlled atmosphere stunning for poultry and meat
Freezing and cooling products and solutions, for food on the premises and during transportation, including:
Bulk nitrogen and carbon dioxide gas for cryogenic freezing
Wide range of environmentally-friendly and traditional refrigerants for mechanical refrigeration
Freezers, chillers, temperature control systems and food equipment
Total food and beverage packaging solutions, including:
Bulk gases and compressed nitrogen, carbon dioxide, oxygen and gas mixtures for modified atmosphere packaging (MAP)
Food storage gases and gas mixtures for packaging, fumigation, sterilization and pest control
Laser gases and equipment for marking "best before" dates on metal cans
Beverage grade bulk gases and packaging systems
Beverage grade compressed and bulk gases, equipment and solutions.
We also offer the following products for industrial facilities:
Welding gases and equipment
Oxygen for water treatment
Instrument calibration gases – scientific mixtures and high-purity gases
Laser gases and equipment for marking "best before" dates on metal cans.


text:
As long time readers may know, we like to offer a run down of the sessions, papers and events at the Annual Meetings of the American Anthropological Association that may be of interest for readers of this blog. This has been made considerably easier the last couple of years by AAA's personal scheduler function, which allows for the creation of sharable schedules. You can see a full* list of these papers and sessions via our shared Google Calendar, here. If you're also a user of Google Calendar, you can easily copy individual events to your own schedule there.
In particular, though, I'd like to highlight a few events that are either directly sponsored or otherwise associated with Anthropoliteia.net. Perhaps the most important of these is the first ever Anthropoliteia "Tweet-Up." Based on the previous success of similar events hosted by Savage Minds (among others), our Editorial Board has decided to extend an invitation to anyone interested to come meet with us–along with a select group of our various Section Editors and Contributors–to discuss, imbibe, and otherwise commiserate. You can find** us Thursday, December 4th from 6-8pm at
Murphy's Irish Pub, around the corner from the conference hotel [UPDATE: Harry's Pub, in the Wardman Park Marriott].
Besides the tweet-up, there are a few official sessions that come out of collaborations on Anthropoliteia and the CFP we circulated earlier this year:
On Wednesday, December 3rd from 4-5:45pm in Washington Room 3 of the Marriott Wardman Park will be the panel "Thinking Through Police, Producing Anthropological Theory: police ethnography as a tool for critical thought," organized by and featuring yours truly, along with Avram Bornstein (John Jay-CUNY), Mirco Gopfert (U Konstanz), Beatrice Jauregui (U Toronto), Matthew Wolf-Meyer (UC Santa Cruz) and Matthew Hull (U Michigan).
On Friday, December 5th from 6:30-8:15pm in the Diplomat Ballroom of the Omni Shoreham will be a roundtable on "Critical Potentialities of the Anthropology of Policing. Accounts of Police, Power and Politics on Public Display?" organized by our own Paul Mutsaers (Tilburg U) and featuring Beatrice Jauregui (U Toronto), Eilat Maoz (U Chicago), Simanti Dasgupta (U Dayton), Daniel Silva (Unicamp), Michelle L Stewart (U Regina), and Craig William Schuetze (UC, Santa Cruz).
Finally, on Saturday, December 6th from 9-10:15am, again in the Diplomat Ballroom of the Omni Shoreham, will be the panel "Violence and Ethics in Ethnographies of Security in Latin America," organized by Stephanie Savell (Brown U), guest editor of this summer's Forum "Security in Brazil: World Cup 2014 and Beyond", and featuring Erika Robb Larkins (U Oklahoma), Aldo Civico (Rutgers U), Stephanie Savell (Brown U), Kristen Drybread (University São Paulo/ NEV) and Danial M. Goldstein (Rutgers U).
We hope to see you all there!* As always, if you notice any oversights or would like to suggest additions send an email to firstname.lastname@example.com ** If you're not sure who to look for, I basically look like this, possibly with shaggier hair. Also, I'll try to be attentive to twitter–@anthropoliteia and @kevinkarpiak–especially towards the beginning


text:
Forward and spot deferred transactions provide qualified customers (commercial counterparts who are precious metals professionals) with discreet, privately negotiated dealings tailored to exact quantity specifications to meet their forward and/or deferred pricing requirements.
Please be advised, the A-Mark trading desk is now open 17 hours per day. The new hours are from


text:
When I was in high school, one of my favorite ways to waste time in class (not recommended) was to play a game called dots and boxes (although at the time we just called it dots). I was very surprised to find later that this game belongs to a class of games called "Impartial Combinatorial Games". These are games where the moves available to the player depend only on the position of the game, and not the player.
In a game of Dots and Boxes, we start with an initial grid with dots at each row and column intersection. At each player's turn, they have the option of drawing either a horizontal or vertical line between two neighboring dots (depending on if the dots are in the same row or column). If a player fills in the last line on a box (the 4th side), we say that player "owns" the box. The game ends when there are no neighboring dots without a line between them. At the conclusion of the game, the player who owns the most dots is declared the winner.
The game is impartial because there is no restriction on which move a player can make other than the fact that a player cannot re-do a move that has already been made (a partial version of this game would be if player one could only move horizontally and player two could only move vertically).
I have implemented a javascript version of this game. Check it out and let me know what you think.
I also spoke earlier about the discovery that this game in particular was an active area of research. I wanted to provide a link to a paper entitled "Solving Dots and Boxes" by Joseph K. Barker and Richard E Korf that speaks about winning strategies for each player in a game of dots and boxes.


text:
O Keeffe s Working Hands 96gm
- Regular price
- Sale price
- Regular price
- Unit price
- /per
Adding product to your cart
We have a 14-day return policy, which means you have 14 days after receiving your item to request a return.
To be eligible for a return, your item must be in the same condition that you received it, unworn or unused, with tags, and in its original packaging. You'll also need the receipt or proof of purchase.
To start a return, you can contact us at email@example.com. If your return is accepted, we'll send you a return shipping label, as well as instructions on how and where to send your package. Items sent back to us without first requesting a return will not be accepted.
You can always contact us for any return question at email@example.com.
All orders are processed within the same day. We will contact you if there are any delays. However, some orders may be despatched within the same day and some may take up to 1 day.
Standard Shipping
The order will arrive within 2-3 business days & will be tracked. Standard Shipping is FREE.
Express Shipping
The order will arrive within one business day. Express Shipping costs £1.99, ordering for the same dispatch has a cut off time of 3:00 pm every day except weekends. Express orders made after 3 pm will be dispatched the next day for next day delivery.
0161 241 6842
Pop by
Unit S Highfield Road, Manchester, M38 9ST


text:
欧博手机版(www.aLLbet8.vip):Years of school closures leave the Philippines with deep scars
MANILA: On Aug 22, schools in the Philippines will finally reopen their doors to students after two and a half years – one of the longest pandemic-induced school closures in the world.
As well as devastating the individual prospects of countless children, the extended hiatus is threatening to leave long-term scars on an economy historically reliant on sending high-skilled workers abroad.
Protracted school closures worsen basic literacy standards and will likely reduce the productivity and earnings of children once they enter the workforce, the World Bank warned in a recent report.
About 10% of Filipinos work abroad and the economy is dependent on remittances sent back by its overseas nurses, teachers and engineers, among other workers.
A steady flow of graduates is also essential to the country's push to establish itself as an outsourcing center for international corporations and to increasing the number of decent jobs closer to home.
"The impact is huge," the country's economic planning chief Arsenio Balisacan said in an interview. "The quality of graduates we produce affects the competitiveness of our labour force."
While protracted school closures have bedevilled many countries – particularly poorer ones – the problem is particularly acute in the Philippines, where the shutdown has been one of the longest in the world according to data from the United Nations Children's Fund.
Even now, full in-person teaching isn't planned until November.,
One reason for the tardiness in reopening is the country's social structure.
Households are mostly composed of extended families so many children live with grandparents who are vulnerable to the virus because of old age, or with other relatives who may have underlying health conditions.
Exacerbating fears of the virus are long-standing logistical issues in poorly funded schools including overcrowding.
Prior to the virus, classes in public schools of more than 60 students were common, necessitating textbook sharing and preventing any meaningful social distancing.
So while parents are dismayed at their children's lack of progress, fear of the virus has kept criticism of the government in check.
Cristina Martinez, a 31-year-old vegetable seller in the coastal town of Hagonoy and mother of four children, said her 10-year-old "can barely read sentences," particularly in English, the language used in science and math textbooks.
"The situation is hard for us, but I think there's not much we can do." — Bloomberg


text:
With over 20 years of stand-up comedy experience, Jim Breuer remains one of today's top entertainers and continues to win over audiences with his off-the-wall humor and lovable personality. Named one of Comedy Central's "100 Greatest Stand-Ups of All Time," Breuer is one of the most recognizable comedians in the business, known for his charismatic stage antics, dead-on impressions, and family-friendly stand-up.
Even as a young student at Valley Stream Central High School in Long Island, NY, Breuer knew he wanted to be a stand-up comedian. After spending several years working comedy clubs across the country, Breuer settled in as a regular on the New York comedy club circuit. After being in New York for only seven months, Breuer landed a gig on the nationally syndicated show, "Uptown Comedy Club," where he spent two seasons. Later he appeared on ABC's "Home Improvement" starring funny man Tim Allen, before making his big break which came in 1995 when he joined the cast of NBC's legendary "Saturday Night Live." During his four years on SNL, Breuer quickly became a fan-favorite for his original character "Goat Boy" and his dead-on impressions of actor Joe Pesci.
Following his success on SNL, Breuer starred alongside Dave Chappelle in the cult favorite film "Half Baked." He has since appeared in the popular films "Zookeeper," "Dick," "Titan A.E." and "Beer League." On the small screen, Breuer hosted MTV's popular "Beach House" and VH1's "Web Junk 20." His other television appearances include "Late Night with Conan O'Brien," "The Daily Show with Jon Stewart," "The Late Late Show with Craig Ferguson," "Jimmy Kimmel Live," "Late Night with Jimmy Fallon," and "The Marriage Ref." Breuer is also a frequent guest on the Howard Stern Show.
In 2008, Breuer set out for his "Breuniversity Tour" with his 85-year-old father and a film crew. The footage that was captured blended together to create "The Jim Breuer Road Journals," which showcased what life is like on the road with a comedian and his father. Videos from that tour also sparked the making of his documentary "More Than Me," which was shown at the 2009 Montreal Film Festival. In July of 2009, Breuer's one-hour Comedy Central special "Let's Clear the Air" premiered with hilarious topics that included what "success" really is, his SNL days and life with his elderly parents, his wife and his three daughters. In 2011, Breuer embarked on a national tour with three of the country's top comedians, Dave Attell, Bill Burr, and Jim Norton, for "The Anti-Social Network" tour. That same year, Breuer's acclaimed autobiography, "I'm Not High: (But I've Got a Lot of Crazy Stories about Life as a Goat Boy, a Dad, and a Spiritual Warrior)," was released on paperback. In the memoir, Breuer sheds light on his early struggles, his rise to fame and the many lessons he's learned along in an extremely funny, yet personal and touching way that fans have never seen before. Most recently, Jim released his all new one hour comedy special on EPIX, "Jim Breuer: Comic Frenzy." The latest special focuses on what Breuer's life (and all of our lives) truly consist of: dealing with the elderly, becoming our parents' caretakers, parenting teenagers, and what it takes to be a "marriage warrior." As an added bonus, Breuer also sheds some light on what it's like to perform on "heavy metal-themed" cruises. It's not nearly as glamorous as one might think.
Throughout the years, Breuer has supported various charities through his comedy, including the Chris Farley Foundation, MusiCares, his local police and fire departments and more. Breuer currently resides in New Jersey where he enjoys spending time with his family, playing pick-up games of baseball, softball and wiffle ball and watching the NY Mets.


text:
Read more from Slate's special issue on science education and give us your best ideas for raising the next generation of scientists and engineers.
On a morning visit to a Northern California middle school, I saw not a single student. The principal showed me around campus, but I didn't see or hear students talking, playing, or moving about. The science lab was empty, as were the library and the playground. It was not a school holiday: It was a state-mandated STAR testing day. The school was in an academic lockdown. A volunteer manned a table filled with cupcakes, a small reward for students at day's end.
This is what the American public school looks like in 2012, driven by obsessive adherence to standardized testing. The fate of children, their schools, and their teachers are based on these school test scores. I wondered what kind of tests the students were taking. The California Department of Education's STAR website has sample test questions, and I started looking through them randomly. Soon, I came across the following reading comprehension question about the proper use of a microscope, shown in the illustration below.
The illustration is the prelude to the actual question, which is:
The microscope lens should initially be placed close to the glass slide:
A. Because focus is achieved by moving closer to the specimen.
B. Because the specimen on the slide will be in perfect focus.
C. To avoid breaking the glass slide when adjusting the focus.
D. To maintain distance from the microscopic stage.
Try to guess the right answer. I'll be honest. I couldn't figure it out. Worse, I didn't care to. Here's how kids answer the question.
A. 28 percent of students gave this response.
B. 22 percent of students gave this response.
C. 41 percent of students gave this response. (Correct response)
D. 8 percent of students gave this response.
Nearly 60 percent of kids do not give the correct response. This is what test designers want. As an educator once told me, if the question was such that everyone got the right answer, then it wouldn't be a good question. The corollary is that there are a lot of things that most kids know that we don't test.
Reading the sample question made me think what it would be like to be tested on the procedure for silencing a cellphone. Imagine how hard it would be if you had never used a cellphone.
As I examined the test question, two things became apparent.
- The test has become a teaching tool. Since students weren't expected to know from experience what a microscope is, the test must explain what a microscope does, what the parts are named, and how to use it.
- It failed to convey that the whole purpose of having a microscope is to see things that you can't see with the naked eye.
I told my son-in-law about this particular question because he had just graduated from the wine program at U.C.–Davis, where he used a microscope quite a bit. He told me that at a recent family event he brought out his microscope to show what a drop of wine looked like under magnification. His grandmother, who had never looked through a microscope before, stepped up to take her first look. "My," she said, "it looks like little grapes." Everyone laughed, thinking she was somehow confused. Her grandson spoke up excitedly telling everyone that Louis Pasteur made the same remark upon seeing yeast cells for the first time under a microscope.
The most disturbing thing about the test question is that the test has become a substitute for direct experience. A drawing replaces reality. Too often in schools we are teaching science from textbooks—that is to say, on paper.
Learning by Doing, Learning by Making
"Learning by doing" was the distillation of the learning philosophy of John Dewey. He wrote: "The school must represent present life—life as real and vital to the child as that which he carries on in the home, in the neighborhood, or on the playground." He also wrote that "education is not preparation for life; education is life itself."
As the publisher of Make magazine and Maker Faire, I find Dewey's views refreshing and relevant. I see the power of engaging kids in science and technology through the practices of making and hands-on experiences, through tinkering and taking things apart. Schools seem to have forgotten that students learn best when they are engaged; in fact, the biggest problem in schools is boredom. Students sit passively, expected to absorb all the content that is thrown at them without much context. The context that's missing is the real world.
Each year at Maker Faire in the Bay Area, we have an Education Day, when kids get to meet makers and see their creative projects. The kids interact with robots, rockets, and all kinds of contraptions. They get to make things themselves. One comment I hear from kids was that the experience was "real." It's a telling comment, because so many kids have come to see school as isolated and artificial, disconnected from the community.
The maker movement has the opportunity to transform education by inviting students to be something other than consumers of education. They can become makers and creators of their own educational lives, moving from being directed to do something to becoming self-directed and independent learners. Increasingly, they can take advantage of new tools for creative expression and for exploring the real world around them. They can be active participants in constructing a new kind of education for the 21st-century, which will promote the creativity and critical thinking we say we value in people like Steve Jobs.
At an educational workshop where I made my case for making, there were a number of rather skeptical educational bureaucrats who kept asking how we assess or measure something that's experiential. How do we measure engagement? I was rather frustrated, to be honest. How do we know children are learning if we can't test it? I put it back to them: "How do we know what we're testing is real learning?"
I continued to think about the questions for several months. Then one day I had it in a sentence. "Making creates evidence of learning." The thing you make—whether it be a robot, rocket, or blinking LED—is evidence that you did something, and there is also an entire process behind making that can be talked about and shared with others. How did you make it? Why? Where did you get the parts? Making is not just about explaining the technical process; it's also about the communication about what you've done.
This kind of conversation is the core of Maker Faire. Makers bring what they've made and share it with others. They answer questions and explain how things work. They get feedback and meet others who have insights into what they've made. We might consider it a performance-based assessment, just like what happens in the work world.
As I walked around the middle school with the principal, we were looking at rooms that could be used to create a maker space for students. We walked into an empty room that once was the metal shop. It was perfect. I could imagine it having tools and materials and workbenches. I could imagine groups of curious kids being active, social, and mobile. She said her students would be very happy. "They never get asked to create anything," she told me.
Also in Slate's special issue on science education: Fred Kaplan explains why another "Sputnik moment" would be impossible. Also, share your ideas for fixing science education in the Hive. This article arises from Future Tense, a joint partnership of Slate, the New America Foundation, and Arizona State University.


text:
About the Natural Language Interfaces GroupThe Natural Language Interfaces (NLI) Group encompasses several laboratories that are involved in Augmentative and Alternative Communication (AAC) research. AAC systems help people with severe disabilities to communicate. The NLI group is interested in improving the efficiency and usability of current AAC devices as well as discovering novel ways in which to aid communication.
NLI Research Staff
NLI Research Labs
Natural Language Processing
Graphical Language Representation
Graphical Language Representation


text:
Welcome, dear reader, to another post in our series on Big Data. If the reader has not read the previous posts in this series, the links can be found at the end of this post, or in the menus, "Big Data" section. In this post, we will cover a technology that has gained quite popularity in the world of Big Data: The Apache Spark.
Created in Berkeley University by AMPLab, the goal of Spark is to provide a computer model, according to the official website, up to 100x faster than a conventional mapreduce Hadoop job. But how it hopes to achieve this performance improvement?
Such gain is based on this one point in Hadoop mapreduce model. During the execution of a Hadoop job, we have 3 times when the data is "stored" in the processing:
- At initial processing, before the map step;
- In the midst of processing, when the data filtered by the map phase is being stored for later stages of sort and reduce;
- At the end of the processing, when the final result is delivered;
In Hadoop, on these three aforementioned moments, we have an IO disk consumption, because the data is stored on disk, rather than kept in memory, including the intermediate step between the steps of map and reduce. In a production environment of Big Data, it is common to have iterative jobs, running several times on a given body of data, using the result of the previous run as input for the next run. It is precisely in this scenario that the Spark has its biggest gain: keeping the data in memory, the access / write of the data becomes much faster, thus ensuring the announced earnings. From this seemingly simple change, the Spark project, which allows constructing jobs following the BSP model (Bulk Synchronous Parallel), was born keeping as much as possible of the data in memory within a run, thus ensuring a fast and scalable computational model. In the picture below we can see the architecture of the Spark and its subprojects, which we will discuss below
From the Spark initial project, 4 subprojects were born, that complement his use. All these modules are already part of the default installation of Spark and they are:
Spark SQL: Similar to what is the Hive for Hadoop, Spark SQL brings a language similar to SQL for data query on a Spark installation;
Spark Streaming: Spark streaming allows the build of streaming style applications, where the data can be read / written during the processing, instead of the traditional model, where results from a process can only be delivered at the end of a execution;
MLlib: Equivalent to Apache Mahout, allows the construction of machine learning processes. Machine learning is a field within computer science, where using of statistical and logical rules, programs can "learn" and draw your own conclusions from a mass of data provided as input, simulating a human reasoning;
GraphX: The Spark GraphX allows processing to be built in the Graph format, allowing the resolution of problems through algorithms like Pert, BFS and DFS.
Spark & Hadoop
The reader may be wondering at this point: may I use Spark or Hadoop in my Big Data project? Like everything in the world of technology, this is no simple answer. Several factors may influence this decision, not only technical, but also business, such as the absence, to date, of major players that provide distributions with commercial support, unlike Hadoop that already has commercial distributions of weight as Cloudera and Hortonworks. Due to his complementary nature – Spark integrates with most of the components that make up Hadoop – however, it is possible that Spark could go for a complementary technology over than a competing platform. An example of this is the distribution of Cloudera itself, which provides a Hadoop distribution that also has a Spark distribution. Thus, we have as an increasingly scenario, the combination of the two technologies, rather than using only one of the two. After all, why should we use only 1, if we can enjoy the best that each has to offer us?
And so we come to the conclusion of another chapter of our series. In the next and last post in our series, we will examine some cases of the use of Big Data in the world, in order that we see in practice all the benefits that the Big Data can offer us. Until next time.
Continue reading


text:
Title: The Voyage of the Dawn Treader
Author: C. S. Lewis
Paperback: 767 pages
Publisher: HarperCollins
Publish Date: 2001
Miscellaneous: The Voyage of the Dawn Treader was published third in the Narnia Series, but was meant to be read fifth by Lewis. The copy I have read is in a complete book.
"Don't they admire you?" asked Lucy.
"Oh, not me," said the magician. "They wouldn't admire me."
"What was it you uglified them for – I mean, what they call uglified?"
"Well, they wouldn't do what they were told. Their work is to mind the garden and raise food – not for me, as they imagine, but for themselves. They wouldn't do it at all if I didn't make them. And of course, for a garden you want water. There is a beautiful spring about half a mile away up the hill. And from that spring there flows a stream which comes right past the garden. All I asked them to do was to take their water from the stream instead of trudging up to the spring with their buckets two or three times a day and tiring themselves out besides spilling half of it on the way back. But they wouldn't see it. In the end they refused point blank."
"Are they as stupid as all that?" asked Lucy.
The Magician sighed. "You wouldn't believe the troubles I've had with them. A few months ago they were all for washing up the plates and knives before dinner: they said it saved time afterwards. I've caught them planting boiled potatoes to save cooking them when they were dug up. One day the cat got into the dairy and twenty of them were at work moving all the milk out; no one thought of moving the cat…."
…now they were jumping in all directions and calling out to one another, "Hey, lads! We're visible again….
"She's caught the old man napping, that little girl did," said the Chief Monopod. "We've beaten him this time….
"But do they dare talk about you like that?" said Lucy. "They seemed to be so afraid of you yesterday. Don't they know you might be listening?"
"That's one of the funny things about the Duffers," said the Magician. "One minute they talk as if I ran everything and overheard everything and was extremely dangerous. The next morning they think they can take me in by tricks that a baby would see through – bless them!"
–The Voyage of the Dawn Treader by C. S. Lewis, pages 501-502
With an opportunity for Mr. Pevensie to lecture in America for sixteen weeks, it is decided that Susan will go with her parents, while Peter prepares for his exams with Professor Kirke, and the two youngest children, Edmund and Lucy, will spend the summer at their Aunt Alberta's house. This prospect is made miserable by the fact they will be forced to spend time with their beastly cousin Eustace, who is a mean-spirited bully. When the three children are in Lucy's bedroom, the picture on the wall comes to life and they are drawn into the world of Narnia, finding themselves aboard the Dawn Treader with their old friend Caspian, now King of Narnia.
Immediately, Eustace makes an intolerable pain of himself, demanding to be taken to the British Consul and threatening to write strongly worded letters to the head of the line for his poor treatment on ship. It isn't until Eustace finds himself in a horrible predicament that he can't bully or talk his way out of that he begins to take a good look at himself, and quickly realizes he doesn't like what he sees.
The Voyage of the Dawn Treader chronicles the quest of King Caspian to discover the fate of the seven Narnian Lords, friends of his father, who were sent off by Caspian's usurping uncle Miraz. Along the way, he discovers the slave trade still continues in some parts of Narnia, dragons do exist, the waters of one island turns objects (and people) into gold, an island where dreams come alive (and not just those wishful-type dreams, but the ones that make you terrified to close your eyes again, too), and more. They're goal is to sail to the Utter East, even to Aslan's country, and to find what lies at the end of the world.
Like the other Narnian tales, The Voyage of the Dawn Treader is a Christian Allegory, though I see this one as the least obvious of all. It is a good adventure tale, and it has a positive message of living your life with courage and honor. This lesson is given through Eustace's self-discovery, Reepicheep's voice of valor and encouragement, Lucy's magically eavesdropping on her schoolmates and disliking what she hears what's said about her, and the admonishment Caspian receives when he decides to abandon his responsibilities as King to live an adventurer's life.
Aslan is seen more in The Voyage of the Dawn Treader than in Prince Caspian, however, his visits and sightings are more private and tailor-made for their specific needs: as a glowing albatross leading the ship to safety, in the artwork of the Magician's book keeping Lucy from falling to the temptation of pride, and as a lion sculpted on the wall of Caspian's quarters. The best Aslan appearance, and the easiest to recognize reference, is at the end of Dawn Treader when the children encounter a lamb who offers them food by a warm fire.
"Please, Lamb," said Lucy, "is this the way to Aslan's country?"
"Not for you," said the Lamb. "For you the door into Aslan's country is from your own world."
"What!" said Edmund. "Is there a way into Aslan's country from our world too?"
"There is a way into my country from all the worlds," said the Lamb; but as he spoke, his snowy white flushed into tawny gold and his size changed and he was Aslan himself, towering above them and scattering light from his mane.
"Oh, Aslan," said Lucy. "Will you tell us how to get into your country from our world?"
"…are you there too, Sir?" said Edmund.
"I am," said Aslan. "But there I have another name…"
–The Voyage of the Dawn Treader by C. S. Lewis, pages 540-541
The Voyage of the Dawn Treader was an interesting adventure, but it lacked a lot of the sense of movement and urgency the previous Narnia books have had. I felt the story dragging in parts, like a ship run aground on one or two occasions, and I had to force myself through to the finish. Even so, there were parts where I said, "Oh! I remember reading that before," which have stuck with me from the time my mom read them to me when I was little (she swears she read them all to us, but I don't remember it). And, since this book was third in publication, I can see why so many people haven't read the whole series. But it ends well, and everyone likes a good ending. I give Dawn Treader 3 out of 5 stars.
Filed under: Book Reviews | Tagged: aslan, Caspian, Christian allegory, Edmund, Lucy, Narnia, Pevensie, Reepicheep, talking animals | Leave a comment »


text:
Diolch yn fawr
Go raibh maith agat
Dank u
धन्यवाद Dhan'yavāda
ขอบคุณ K̄hxbkhuṇ
감사합니다 gamsahabnida
Благодаря Blagodarya
Terima kasih
ありがとう Arigatō
Спасибо Spasibo Дзякуй
תודה אַ דאַנק 'a d'anq
Terima kasih
Спасибі Spasybi
Hvala vam
Teşekkür ederim
Þakka þér
Cảm ơn bạn
Хвала Hvala
Σας ευχαριστώ Sas ef̱charistó̱
Thank you to the over 9,999 visitors to the Stanislaw Rajmund Burzynski, Didymus Judas Thomas' Hipocritical Oath Blog – Merci, Danke, Grazie, Gracias, Dziękuję, Arigatō ありがとう
Tag Archives: Germany
Thank you to the over 9,999 visitors to the Stanislaw Rajmund Burzynski, Didymus Judas Thomas' Hipocritical Oath Blog – Merci, Danke, Grazie, Gracias, Dziękuję, Arigatō ありがとう
Diolch yn fawr
Go raibh maith agat
Dank u
धन्यवाद Dhan'yavāda
ขอบคุณ K̄hxbkhuṇ
감사합니다 gamsahabnida
Благодаря Blagodarya
Terima kasih
ありがとう Arigatō
Спасибо Spasibo Дзякуй
תודה אַ דאַנק 'a d'anq
Terima kasih
Спасибі Spasybi
Hvala vam
Teşekkür ederim
Þakka þér
Cảm ơn bạn
Хвала Hvala
Σας ευχαριστώ Sas ef̱charistó̱
Thank you to the over 9,000 visitors to the Stanislaw Rajmund Burzynski, Didymus Judas Thomas' Hipocritical Oath Blog – Gracias, Merci, Danke, Grazie, Dziękuję, Arigatō ありがとう
Thank you to the over 9,000 visitors to the Stanislaw Rajmund Burzynski, Didymus Judas Thomas' Hipocritical Oath Blog – Gracias, Merci, Danke, Grazie, Dziękuję, Arigatō ありがとう
Views – Country
5,269 – United States
1,823 – Canada
881 – United Kingdom
Diolch yn fawr
328 – Australia
78 – Ireland – Go raibh maith agat
44 – Netherlands – Dank u
39 – India – धन्यवाद Dhan'yavāda
35 – New Zealand
35 – Sweden – Tack
32 – Thailand – ขอบคุณ K̄hxbkhuṇ
30 – Germany – Danke
24 – Poland – Dziękuję
21 – France – Merci
18 – Denmark – Tak
17 – Republic of Korea – 감사합니다 gamsahabnida
17 – Bulgaria – Благодаря Blagodarya
17 – Philippines – Gracias
15 – Mexico – Gracias
15 – Belgium
14 – Malaysia – Terima kasih
14 – Norway – Takk
13 – Italy – Grazie
12 – Japan – ありがとう Arigatō
12 – Romania – Mulțumesc
11 – Russian Federation – Спасибо Spasibo Дзякуй Dziakuj
10 – Spain – Gracias
9 – Switzerland
9 – Slovakia – Ďakujem
8 – Brazil – Obrigado
8 – Singapore
7 – South Africa – Dankie
6 – Estonia – Aitäh
6 – Taiwan
6 – Czech Republic – Děkuji
6 – Israel – תודה אַ דאַנק 'a d'anq
6 – Finland – Kiitos
5 – Indonesia – Terima kasih
5 – Chile – Gracias
5 – Ukraine – Спасибі Spasybi
3 – Slovenia – Hvala vam
3 – Argentina – Gracias
3 – Turkey – Teşekkür ederim
3 – Portugal – Obrigado
3 – Austria
3 – Honduras – Gracias
3 – Cambodia
3 – Iceland – Þakka þér
2 – Peru – Gracias
2 – Viet Nam – Cảm ơn bạn
2 – Bermuda
2 – Serbia – Хвала Hvala
2 – Latvia – Paldies
2 – Moldova
2 – Cyprus
2 – Greece – Σας ευχαριστώ Sas ef̱charistó̱
2 – Lithuania – Ačiū
1 – Hong Kong
1 – Ghana
1 – Myanmar
1 – Columbia – Gracias
1 – Pakistan
1 – Croatia – Hvala
1 – Nepal
1 – Trinidad and Tobago
1 – Egypt
1 – Hungary – Köszönöm
1 – Albania – Falemnderit
1 – Bahamas
1 – Bosnia and Herzegovina
1 – Isle of Man
1 – Morocco
1 – Guatemala – Gracias
1 – United Arab Emirates – شكرا
1 – Kenya
1 – Zimbabwe
A Cancer HackFest on National Geographics' #NatGeo ScienceBlogs . com/Insolence:
DJT's Comments – September 28, 2013 "The Skeptics™" Burzynski discussion: By Bob Blaskiewicz – 2:19:51
Well as I put in my about page, I agreed with the juror that he was neither guilty or innocent
So, so since I see all this opposition by these Skeptics, and I see that the they're getting all of their facts straight
I decided to take the position of being a Skeptic Skeptic
In other words I am skeptical of Skeptics who do not fact-check their information before they post it on social media
And since I see ahhh y'all pretty much trying to take over the net with y'all's information I decided to come back and correct all the false information that was being put out by other Skeptics
Well the major issue is that the FDA's own information says if phase 3 trials are approved – phase 2 trials is to see if there's evidence of effectiveness
And so if phase 3 trials are approved, that means you've provided evidence of effectiveness
That's the FDA's own information – I have that clearly on my blog
Also the FDA has given Burzynski uhhh Orphan Drug Designation in 2004 for uhhh brainstem glioma and then in 2009 for all gliomas
So that must mean that there is evidence of effectiveness, otherwise I don't think they would be doing that
Well the issue is he was given 2 phase 3 trials that we know of
One was on uh Clinical Trials . gov – the one about eye cancer
The vision cancer
And then the other one was not posted on there, but then again the FDA has said, and I posted this on my blog because I specifically contacted and asked them and they said we don't post all clinical trials on our web-site
And so he obviously had that other one about brainstem glioma, that he was trying to get started
But the other issue is that Skeptics have posted on there that he could not get that accelerated approval until he had published a phase 2 trial and that is exactly not the case because other drugs have been given accelerated approval before their results were published in phase 2 clinical trial publications, cuz, so that question remains as well
Well, what we do know is that in the movie, Merola showed that one page rejection from The Lancet
where Burzynski was trying to show his results from like 8 to 16 years, and they said we think your uh publication would be seen best elsewhere, or some ridiculous statement like that
And so, I thought that funny of The Lancet
Of course, I understand their 2nd response, which came out, which Eric posted on his Facebook page, y'all, that y'all have talked about – that, you know, they're busy, they get a lot of
I understand that, so obviously he would have to look for a different publication for both of those, things he's trying to get published
Well a lot of the time I'm making fun of y'all's favorite oncologist, the way he words his blogs, and uhmmm I cite specifically from the FDA, from from the National Cancer Institute, from these other scientific sources, from scientific publications
I give people specific information so they can fact-check me, unlike a lot of The Skeptics who just go out there and say things and publish things on social media, they provide no back-up for their uhhh sayings
And so when I critique an oncologist or any other Skeptic I always provide source material so people can always fact-check me and I specifically said that people should fact-check everything ummm that the oncologist should say because he has, I've proven him to be frequently incorrect about his information and misleading
And so I've tried to add those things and allow people to search, on specific things like publications, or what I posted about The Lancet, or specifically about The Skeptics, or specifically about the oncologist
So whenever I see something posted new on Twitter, by y'all, sometimes I'll check it out and sometimes I won't, and sometimes I'll comment on it
I was, on there just yesterday to see some more of your post on there
Well the thing is, when you accepted this hangout, I published my newest blog article and I specifically listed all the information I had critiqued from you previously including Amelia, and I posted the specific Twitter responses by BurzynskiMovie; which is probably Eric, to your issues with Amelia, and he disagrees with what the oncologist posted, and so I pretty much let his Twitter responses stand to what the oncologist said
Well I also did a critique of the newspaper story that was put out about Amelia in the U.K.
And they had 2, 2 patients that were dealt with
I believe, yes
And one of the patients, Burzynski has specifically published in one of his scientific publications that maximum dosage is not reached for a month
So if someone, so if someone only goes in there and has treatment for a month, they're not even, you know, they're finally going to reach the uh maximum dosage
And I think that was maybe the case with Luna, I think she was only there for a month
Well my only thing is, uh, we know that sometimes he will go to a maximum dosage, or you know, the suggested dosage, but he will back down off it, in fact in the uh adverse effects you mentioned those are specifically adverse effects mentioned in his publications, and when that happens normally they will subside within 24 to 48 hours is what it says once you take them off the treatment and let, you know, those conditions take care of themselves, and then you will slowly raise the medication again
So, you know, it just didn't tell, if only one month of treatment was enough to even start to do anything for her
Well the thing is, the FDA has approved phase 3, and also given them the Orphan Drug Designation, which means they should have some knowledge about what's going on, I would think
Plus we don't know for sure, we've heard about, ummm, some of the things supposedly the oncologist has talked about, which is cutting off the blood flow, to the tumor, which is something that some uhhh drugs can do, and I think that's one of the things Burzynski has tried to do, ah he's specifically mentioned it in his personalized treatment
But I don't know for sure if it's also something that's done with the ANP's in just the clinical trials environment
So, that could be a possibility
Well what I find interesting about these other doctors is like like the doctors mentioned in the movie and BBC Panorama's report and in some of these newspaper articles where they are mentioned again is that these doctors never do a review of Burzynski's scientific publications and including our favorite oncologist who refuses to do so
Oh yeah he says he's read everything but uh you know he claims that he's uhmmm reviewed, reviewed uh Burzynski's personalized gene targeted therapy but he, but then just a few months ago he admitted, you know, I don't know where Burzynski says which genes are targeted by antineoplastons
And I pointed out which specific publications that Burzynski published, publications which specifically mention which genes are targeted by antineoplastons, and I said how can you claim that you've read and reviewed every Burzynski publication and you didn't know which genes are targeted by antineoplastons when that's specifically in the publications ?
To me that tells me that you do not know how antineoplastons work be because you just admitted you don't know which genes Burzynski talks about
I mean that's just funny as heck to me that he would say that
Well I've, I've got it on my blog
I mean I can forward it to you at some point
But I agree with you about I don't remember seeing anything about antineoplastons cutting off the blood flow to the, you know the blood brain barrier for sure either
Well I think I know the point that you're getting at uhhh about the IRB's and all that good stuff
All I can say is that, you know the FDA can come in with any amount of investigators and say that you did this or that but you have the opportunity to respond, and so they can pretty much say anything, it's only when the final report comes out that you can take that to the bank
And so all this speculation about what a investigative team may say about the clinic is, to me just like someone going into a lawsuit and saying so-and-so did this, you know, can you prove that, you know, did so-and-so do that
So it's the same thing with the FDA, these um little reports, the final report is what counts, and so, also what I find interesting is some of Burzynski's publications specifically said, you know this particular uh clinical trial, the IRB was agreed upon by the FDA
Well if if the FDA agreed upon it, you know, then some questions should arise about exactly what did the FDA agree upon
What would we find out from a Freedom of Information Act request on that ?
And, and what I also found interesting is when I did research on other clinical trials for brainstem glioma I found, you know, all these other science based medicine studies where 374 children had died in their studies
And what I found interesting is back in 1999, they reported on a clinical trial, they had better results then all these clinical trials afterwards
Well, I would have to find you one, there were like 3
There were like 3 major ones that Burzynski has mentioned in his publications to cross-reference his trials versus their trials as far as the results
And so, I, there was one back in 1999 that had better results than a lot of these clinical trials that come afterwards
So when we talk about, you know, what's really right for the patients well we can see that the drug companies want to test their drugs through clinical trials and, you know, and if your kid dies, well, unfortunately the kid dies
Even though we showed better results in 1999 with a different type of treatment, you would have thought that maybe they would have poured more investment into that particular treatment but that's not necessarily how the clinical trial system works
Well here's my point, I mean, y'all probably get a better sense from, ummm, Hymas, about what's going on with that
From her uh fiancé, or husband, whatever his status happens to be right now
And uh also from Ric, uh they're more closer to Burzynski than I am, because I have never met Burzynski, I have never e-mailed Burzynski, uhmmm never talked to Burzynski, never met him, blah blah blah
Uh, my sense is that since 1996 when the FDA talked about antineoplastons, that specific FDA Commissioner that was in charge at the time, he set out 7 major points about how there was going to be less people required and there was going to be less paperwork, there was going to be less stringent things about Partial Response
And so, to me, the FDA is the final source to go to when people want to complain about how long their trials have lasted uh because the FDA is bottom line, you know, in charge of that
And my other point is that, uhmmm, when these trials finish, as I've pointed out on my blog, M.D. Anderson finished a trial in 2006 and didn't publish the results electronically until January of this year
So, just think
Burzynski's 1st trial we know that finished in 2009
So we would still have more years to go before he caught up to M.D. Anderson as far as publishing
So for him to actually be trying to publish stuff now and The Lancet not publishing because they have other stuff to do, put in there, that's understandable
So, we know that he's trying to publish, uh but they're going to keep it close to the vest obviously, from, from how they do their things, and where they're trying to publish
And plus, like I've said before
We've still got the accelerated approval thing that's out there, you know, like the FDA's given Temodar and, and Avastin, and another drug, whereas they're not doing the same thing for antineoplastons, eve even though for all intents and purposes from what we know, antineoplastons have had better success rates than Temodar and Avastin when they were approved
Well from the information that's been published in certain um publications
And in, and in not only Burzynski's but elsewhere in, in newspapers or articles, or such like that
Well what I found interesting is when the FDA approved these other 1 or 2 drugs, some of them specifically said that, uhhh, some of these drugs had, you know, better survivability or they showed no better rate than any previous treatment but we're approving it anyway
Basically that's what the publication said and I published this on my blog in an article specifically about, you know, those 2 or 3 drugs that the FDA approved for brainstem or brain related cancers
And so, you know, I'm not going to buy that argument about that, about that specific thing
Well one of these newspaper articles specifically said, you know, Avastin would maybe keep you alive for maybe 4 more months
So, you know, take that
Well, we can wonder if some of Burzynski's results are the same, otherwise why would the FDA say, you know, give the ODD, why would the FDA give the phase 3 approval
Plus I don't buy some of these doctors coming out and saying stuff, they have the opportunity just like the other doctors in Egypt, in Russia, in Germany, in, in Poland in China in Taiwan that have done antineoplaston studies, I'm like, these people can do antineoplaston studies so what's the excuse for all these other doctors who say that they supposedly can't do them
You know, the information's out there and
and like these other doctors can do it
Well, we kind of know that that's a fact
Well what we know from 1996 from Burzynski's own information that he's published, is that not only does he have the original parent antineoplastons, but he's developed 2nd and 3rd generations, but he can't just stop in the middle of his clinical trial and use the 2nd and 3rd generations which may be better
He can't uh use these other types of um antineoplastons that other researchers, researchers like Egypt, or Japan have found um that may be better because he can't just switch in the middle of the clinical trial
Now if he, if the FDA approves his product, well then, maybe he can roll out the 2nd and 3rd generation and these other types of antineoplastons that may be less harsh, but that's all he's got to work on and that takes us back to the FDA, having control over the entire process, as far as the paperwork, how many people are in the trials, etcetera
Well I find it interesting that you talk about the cost, because I've done a lot of research about the cost, and I was just looking at the cost again this morning, and put it into that particular blog article I was talking about, that I did for this particular program
And, um
The thing that's funny is that people can say, ohhh Burzynski charges a lot, but the fact is, so does chemo, radiation, and some of these newspaper articles that have been published, and specifically in the movie, Burzynski 2, one of the people mentioned how much someone was paying for standard treatment
And I noticed our
favorite oncologist didn't comment about that in his movie review
Well what I find interesting, you know, I'm not sure how people think he's supposed to pay for the clinical trials, you know, if he's supposed to go into debt, millions of dollars
I find that funny considering the FDA approved phase 3, has given him ODD for brainstem glioma and also also all gliomas
You know, that's kind of ridiculous
And the people
gettin' off about his house, well who cares ?
They don't know where his money came for that particular source
Well, you know, when you have good tax lawyers your tax lawyers will tell you how to structure things, and everybody in America has the right to structure their taxes in a manner that effectively serves them according to our Supreme Court
So, if you have a tax lawyer who tells you, hey this is the best way to do it, to save money, well, you may do that uh based upon your lawyer's advice
So, maybe Burzynski has taken his tax lawyers advice, just like I'm sure he's taken Richard Jaffe's ad advice (laugh), which has proved well, for him
You know, you know
That's another thing
Well I guess we could ask, you know, Ben and Laura Hymas
What was their experience, you know ?
Did they have, did she have to drink uh a lot of water because she was thirsty ?
You know, did she have to drink a lot of water due to the high sodium ?
So I would ask her about her personal experience instead of saying, you know, instead of quoting some of these other people
Well we all know the FDA is in charge of this, and so hopefully they know what's going on
No, I'm sure the FDA can look at the records because Burzynski sent them 2.5 million pages according to our friend Fabio
And uh, you know just something the doctors who came in and did the little ol' one day, 6 patient records, where they reviewed all the records and slides, and MRI's, etcetera, you know they can do the same thing, the FDA can do the same thing with all these patients
And see the same MRI's and scans, etcetera
I mean, we, we know that with all these 374 children I mentioned dying in other science-based medicine clinical trials
I mean, they, FDA probably went through all their records
And, so, all these people didn't look good either but, you know, the FDA still gave approval to Avastin and Te Temodar even though a lot of people died in their clinical trials
I mean, we could agree that since
Burzynski's publication says that it's going to take a month to get up to required dosage, and so we know, the tumor can still grow, like he said, up to 50%, he specifically acknowledges that in his publication, so, we know that can happen
Well we know from his own publications, he says he can't just go in and start giving the maximum dose, or recommended dose right off the bat because a particular condition will occur, and he specifically mentions, in the publications what that condition is, I don't remember it right off the top of my head
But then again, his 2nd generation, his 3rd generation, his other form of antineoplastons that may work in the future, if approved, well those could possibly have the same uh adverse effects that the current parent generation have
But we don't know, and like I said the FDA I'm sure knows because they have all the records, we don't have them, and so unlike our favorite oncologist I'm not going to speculate, about what the FDA knows and I do not know
Well we know they stopped this particular trial, supposedly because a patient died
So what's the hold-up ?
I mean, hopefully they've done an autopsy
What was found
And we don't have a final report from the FDA on what the findings wer
I don't remember specifically
Possibly not
Well he's using the same 1st generation drug
Well I'm sure a lot of people leave the doctors office not knowing things, for decades
Well we know the contin, the tumors can uh continue to grow for awhile, at least, and certain effects that they probably would
Well I'm sure, I mean, it's going to continue to grow, in any other clinical trial too, for a certain awhile
I mean like
Well we know that all these other kids died in these science-based medicine trials, and, you know, we can assume that that was the case there too
The FDA not giving him phase 3 approval, the FDA not giving him ODD designation
And showing that, and showing the FDA that there's evidence of effectiveness
Not until the FDA says it doesn't work
Well they seem to be doing a good job at it
Well I'm sure, I'm sure they wouldn't have done things if they didn't see some evidence that it was working
No I haven't read it
I know what it's called
Well I'm just gonna say, you know, the F, the FDA doing what they've done, since they approved those 72 initial trials, pretty much speaks for itself
I mean they've had every opportunity to shut this down, since then
No, I'm just concentrating on what we're doing
Well #1 I don't think the one with brainstem glioma where they wanted to use radiation with ANP was really the right way to go, I mean he's already proven that uh he seems to have better results without
first starting radiation
Yeah but the thing is radi, I, the FDA was not saying, ok, one study, one side of the study we're only going to use ANP, in the other side of the study we're going to use radiation and and ANP like like they would normally do
No, they wanted to make him use radiation in both sides of the study
They don't do that with other drugs
Well I don't buy anything Guy Chapman sells, considering his past record
Well his theories are suspect, anything he hands out, let me tell ya
But the question may be bogus, because of where the messenger has been bogus a lot of times before
Well I'm just gonna say what I think about Chapman because he's proven himself, many times to be questionable
I don't see him on my blog responding to my criticism
That's like, that's like saying that Gorski's web-site is disorganized, his blog is like anti vaccine one day, Burzynski the next, blah blah blah
Well how would I know ?
I don't have
Well you didn't when I tried to get you to do stuff the 1st time, did ya ?
Well I, the most, the mostly, excuse me, the most recent article I posted on there is the one about this particular conversation, where I went through all your comments that you had posted, and my response to them
And so I tried to consolidate everything into one, particular article
And that's the newest article
Well I thought that was pretty funny because doing biblical research, you come upon, Didymus Judas Thomas, or he's all, also known by other names
He's basically The Skeptic
And so, like I said, I consider myself to be Skeptic of The Skeptics
I thought it was apropos
Of course
I'm doubting The Skeptics
Well I like how The Skeptics say, you know, all of Burzynski's successes over the years are anecdotal and uh I consider on the same way that everything negative about Burzynski is anecdotal
Well my point is he's proven them to the FDA because they're the ones
Could be, but I would have to read, read the
Well when it comes to Guy Chapman, yeah
You still there ?
Yeah, something cut off there for awhile
Well I would certainly look at that, but then again I would also look at the FDA granting him Orphan Drug Designation
Orphan Drug for brainstem glioma and all gliomas
Right, it's both AS10 AS2-1 and AS
Well not really, since you mentioned that you'd go in and look at my most recent article, anything you show in there or any reply you give is going to cover, what we've gone over
And so we can re debate it there
Well I've specifically stated on my blog that Marc Stephens uh obviously didn't know what he was doing and went about it the wrong way
My position was he should of bou, got around it, gone about it the way I did, which is, I blog, and show where Rhys is wrong, I blog and show where Gorski is wrong, I blog and show where you are wrong, or Josephine Jones, or Guy Chapman, etcetera
And, eh, y'all have every opportunity to come on my blog, and I've had very few takers, uh, one claiming to be from Wikipedia, who I shot down
And hasn't come back
So, you know, I am welcome to anybody trying to come on my blog, and prove what I posted is wrong, and debate anything
Unlike some of The Skeptics I don't block people on my blog
I don't give lame reasons for blocking people on my blog because I'm an American and I actually believe in "Free Speech"
Well to me it is when Forbes removes all my comments, in response to Skeptics some, and I showed this from screen-shots
You know, stuff like that
Oh no
It wasn't down-voted
They, I mean I've got screen-shots of where my comments were there, between other people's comments, and uh, and they just decided to remove all my comments, and I blogged specifically about, you know, what they did and, uh, Gorski's good friend and pal who authored that particular article
So I, I like how The Skeptics run things, you know
Well I think that people who really believe in "Free Speech," and when it's done rationally, I mean, Gorski would never, really respond to any of my questions, so I
Well I know that he specifically removed a review I did uh of his review of Burzynski I on his web, on his blog
But he's pretty much left a lot of my comments up that I've seen
Uh, but he never really responded to my questions about, what he based his beliefs upon
Well I would think, if you're going to base your position on a certain thing, and then you can't back it up with scientific literature, uh, you should answer, maybe not specifically to me, but answer the question
Answer to your readers
You know, I can tell his readers come on my blog because it shows that they come on my blog
Well the reason I have so many Twitter things is because, obviously, some of The Skeptics will be on there lying about some tweet I sent, and so Wikipedia, excuse me Twitter will do a little ol', do their little, hey we're going to block your account while we do blah blah blah, and I'm not gonna waste my time, going through their little review process, I'll just create another uh Twitter address because, like, you know, if you read the Twitter information you can have a ridiculous amount of uh Twitter I.D.'s, and I'll just use another Twitter I.D. and continue on
And so Wikipedia can say what they want, because I've only ever used one I.P., I've only got on there during one time, and when they finally said hey, you know, we're not gonna uh grant your appeal, I completely left their web-site alone, so all that stuff
that they post
So all that garbage that they posted about me, about how I supposedly got on-line, on these other articles is just entirely B.S.
And if they can prove otherwise, I'd sure like to see it
But that's what y'all always say
That's what y'all like to say, about everything
Yeah I'm sure that's what they like to say
I mean, you can report an e-mail, or report a twit, and they'll block it
But um they'll never come back and say, and this is why we blocked you, for this particular twit, for this particular reason
Wikipedia is a joke
Oh sure, I'm sure, that's no problem
I don't have any problem with them locking that
You know, I could tell when I was on there, and when Merola was on there, because he had a different I.P. address than me, I could tell they were his questions because of the way they were formed
So I said, well they're not answering his questions, I'll just take on that role, and uh ask his questions and ask further questions, and they didn't wanna deal with it, you know
Expose them for what ?
For doing what they do, which is basically provide false information and one-sided information ?
Oh, please
They get on there and they say hey, Lola Quinlan filed a lawsuit, but they don't tell you anything else
They don't tell you, you know, Jaffe's side of the story, and her lawyer's side of the story
Oh Jaffe's on there but on that specific article about Lola, they didn't say, here's the article that was posted on uh Lola's attorney's web-site that, that mentions both his responses and Jaffe's responses, to the uh lawsuit
Uh, trust me, I tried to add that and they wouldn't add it
You know, The Skeptics like to be nasty, and so, I've been like Josephine Jones
If she wants to play anonymous, I'll play anonymous
Well, I don't threaten people
I don't threaten Gorski
I don't send letters to people's employers
I deal with them directly, and, you know, if if they won't answer questions, then, you know, I'll just post them on my blog for other people to see, and question uh themselves
Like I said, I'm going to be like Josephine Jones
Because I've said so
I'm not even in Texas
I was born in Texas, but I don't live in Texas
I don't even, didn't even, uh live in Houston
Wasn't even close to Houston
Oh, of course, I, I've seen a lot of stuff goes on Twitter
I've see y'all saying "Oh, we're "The Skeptics" and y'all know are names," but, there's a lot of Skeptics that post on there with pseudonyms, also
Well, I'm just not sure how some of these uh Skeptics will react considering their past behavior
I mean, when Skeptics refuse to, I mean they block you on your blogs
They block your comments
You know, they decide, "Well, I'm maybe going to accept one comment from you, but I won't accept anymore
You know, to me that's just ridiculous
Uh, the action on Forbes that happened, the action on The Guardian that happened, where, you know, you had someone on Gorski's blog basically lie to the Gua, to The Guardian to get them to get them to uh block my comment
So, you know, I'm Skeptical of The Skeptics and their uh and what they would do
Not really
I like my anonymity just like Josephine Jones likes hers
I mean, I will read her stuff and reply to it and treat it seriously jus, just like any other blogger
Well the thing is, some of these Skeptics use names, and they're not necessarily their real names
So, you know, I've seen
Well I think that some people just have bad manners
I mean see, I've seen Skeptics on Twitter basically harass someone pro-Burzynski and keep sending them tweets, and that person specifically send them a tweet saying please keep, stop sending me tweets
You know, they didn't go in and ask Twitter to block the, that particular person
That person just kept sending them tweets
So, you know, I've seen that stuff before
Yeah, I'll look at it, and if you notice, I don't uh, I usually don't reply to Skeptics individually because I pretty much figure that y'all are gonna try and get my next account blocked whenever I do that kind of junk, so, well, you know, I just post what I want to post, under the Hashtag
Well I'll just keep reviewing the, any inaccurate statements I see posted
You know, it depends on if it's Gorski, you know
Gorski's gone on there and posted inaccurate stuff, and I call him out, you know he's basically said on his blog, you know, if I do something inaccurate, you know, I'll 'fess up to it
Well, I've pointed out where he's done that and said "Hey, you said you were gonna 'fess up to it"
If I said on my blog that I was going to 'fess up to doing something wrong, and you caught me, well, then I should, come out and say, "Okay, you got me"
But Gorski won't even do that, you know, he just continues to go on down the road, as if
I mean one of the
I find, I find
You know, I'm just going to let the FDA do their job, and let y'all speculate all y'all want
Uh, I mean
See, I'm here for full discussion
And y'all don't seem to want to discuss, after y'all just go out there and spam the Internet with garbage, that you don't back-up with citations and references and links
But some of your other stuff that you tweeted that you haven't backed up with links, and some of the stuff on thehoustoncancerquack isn't backed-up with links, and Gorski's stuff
Well, that and the anp4all one
isn't backed up
When the FDA says he's wrong
I mean, I'm not, I'm not just gonna accept your story
Burzynski provides the FDA with the evidence, and the FDA makes the
the FDA doesn't approve a drug
if something's not proved
Well you know that he's trying
I mean, y'all can sit there and jump up and down all you want
Well, I'm gonna go with what the FDA is gonna do still because they're running the show
What I find funny is that y'all complain, "Well, he hasn't published, uh a final report"
Well his 1st final, was completed in 2009, and like I said, the M.D. Anderson 2006 study wasn't published until 2, 2013
I mean, so y'all can jump up and down all you want
Y'all want a final report
Well, the final report will be done when the clinical trial is over
Well, unless you're The Lancet, I guess
Well, I'm not gonna get into speculation, I'm just going to wait and see
Well how have I been speculating ?
what the journals keep saying, in response
You know, are they going to give The Lancet response, like they did in 2 hours and such, saying, "Well, we think your message would be best heard elsewhere," or they gonna gonna give The Lancet response of, "Well, we don't have room in our publication this time, well, because we're full up, so, try and pick another place
Well, you like to jump up and down with the 15 year quote, but then again I always get back to, Hey, it's when, when the report, when the clinical trial is done
Not that he's been practicing medicine medicine for 36 years, or whatever, it's when the clin, clinical trial was done
The FDA A believes there is evidence of efficacy
Well, we don't know that
We don't have the Freedom of Information Act information
Well, we know what happened in the movie because Eric particularly covered that when they tried to get what, what, was it 200 or 300 something institutions to take on a phase 3, and they refused
Well, Eric gave the reasons that they said they would not take a particular uh phase 3
And so using that excuse that you you just gave there, I'm not even gonna buy that one, because that's not one of the reasons
Eric said they gave
Well I'm
Well, I'm, I'm sure that they're going to keep you appraised just like they have in the past, just like Eric has done in the past
I mean, we'll see what happens with the Japanese publication
Well that's like me asking "How long is it going to take for y'all's, y'all's Skeptics to respond to my questions ?"
Because y'all haven't been forthcoming
Well, he gave you The Lancet information and he posted the e-mail in the movie, and Josephine Jones posted a copy of it
Well, y'all are free to, you know, claim that all you want, because I don't always agree with Eric, and uh, he's free to express his opinion
Well I don't necessarily believe, what Eric would say about, you know, The Lancet that refused to publish the 2nd one, for the reasons he stated, and which y'all have commented on, including Gorski
You know, I don't necessarily agree with that
I am more agreeable to y'all, saying that, you know, they're busy, they've got other things to do, but I'm kind of still laughing at their 1st response which he showed in the movie about how they felt about, you know his results would be better in some other publication
I thought that was kind of a ridiculous response to give someone
Well you would think that if its a form letter they would use the same form that they used the 2nd time
You know, they didn't use the same wording that they used the 1st time
I would have think that, you know, their 2nd comment
Nah, I'm not saying that they did that all
I'm just sayin', you know, that they gave, 2 different responses, and I would think that the 2nd one they gave
Well I find it funny, something along the lines of, you know, "We believe your message would be received better elsewhere," you know
I don't see that as a normal response, a scientific publication would send to someone trying to publish something
I mean, to me that sounds, like, if you're doing that, and you're The Lancet Oncology, maybe you need to set some different procedures in place, 'cuz you would think that with such a great scientific peer-reviewed magazine, that they would have structured things in as far as how they do their operations
Well, I'm sure, I'm sure Gorski would have a comment about that, as he's commented previously about how he thinks uh Burzynski should publish
Like I said before
Like I said before on my blog, you know, even if Burzynski publishes his phase 2 information, Gorski can just jump up and down and say, "Well, that just shows evidence of efficacy, you know, it's not phase 3, so it doesn't really prove it"
So then he can go on, you know, for however many years he wants to
This is, this is a guy who must phone it in because, he went in there and posted the old Josephine Jones response that, you know, no drugs had been approved by the FDA without their final phase 2 publication 1st being published, which was not a factual statement, and you've made the same statement
So I, I'm thinking that Gorski just bought her statement and took it and ran with it, and before he fact-checked it, and what, what happened, it was wrong
I mean, Gorski needs to stop phoning stuff in, and check his sources before he posts stuff, because I've found many cases where, he hasn't seemed to do that, and that's why I question him
Well, I found it interesting that uh the one on the, Burzynski 2, you know he gave his ex excuses for not, working with uh, that patient, and, but yet, he was the same doctor that treated a another Burzynski patient, according to the movie
I mean, so what does he do ?
Pick and choose ?
Or do doctors pick and choose over there in Britain ?
Well, the movie didn't say anything
Well, I fail to see these doctors on there, providing any factual information, anywhere on the Internet about, uh their disagreements, in a serious way, instead of just making these over-broad statements, you know, "He hasn't published anything in the blah blah blah," and
Well, he's provided some data, and specifically 4 publications
He's given more than the case studies
He's done more than the case studies
He's specifically given uh, almost all the information om an oncologist would want
And Gorski, and Gorski
I mean, I love Gorski, but he comes up with these stupid excuses like, "Well, Burzynski is not an oncologist"
Well, Gorski doesn't go go in there and look at his other, his phase 2 clinical trial publications, as far as the preliminary reports, and look at the co-authors, and see if any of those guys are oncologists, and that they're working with Gorski, I mean they're working with Burzynski
I find that ridiculous
Well y'all, y'all can call things what y'all want
I mean, y'all can give these, fallacy arguments and all that garbage that y'all like, because that's what y'all like to talk about instead of dealing with the issues
I mean, Gorski doesn't want to deal with the issues
Hey, I've said it to Gorski
He liked to back his stuff up on the Mayo study, yet he wouldn't, he wouldn't uh debate about the Mayo study
He likes to say, "Well, Burzynski is not an oncologist," but he won't, say Hey, look at the publications, are any of the guys on the publications oncologists ?
We know that Gorski, we know that Burzynski works with oncologists in his practice
So, just because Burzynski himself is not an an oncologist, does not necessarily mean anything
Do we need to go out, onto PubMed, and, and review every particular person that's published something about cancer and see if they're all oncologists ?
I mean, Gorski will just
post a lot of stuff without backing it up
Well, I, you know, that's up to someone's opinion, considering some of the information that's that the FDA has accepted, as far as giving these guys approval
How did I say I, I didn't trust them ?
Well, I didn't say that they weren't trustworthy, I just raised questions that no one wants to answer about 'em
No, I'm just sayin' that I've raised questions and none of The Skeptics wanna to uh talk about 'em
Well, to me the FDA owes Burzynski for a lot of the garbage they pulled off against him (laugh), not to say, you know, they owe him in that way, but they owed him
Well, we know a lot stuff they did, but that still doesn't impress me that they pulled out of the prosecution
I mean
Well I find it interesting a lot of this uh, a lot of these letters that were provided between, you know, the government and Burzynski, when the uh phase 2 study was going on, at the behest of the NCI
You know, anybody who reads that stuff knows, that when just ignore the person that's been doing, do treating their patients for 20 something years, or close to 20 years, and you change the protocol without his approval, and you don't use the drugs in the manner that he knows works
Well, he says they work together and they're not going to work if you don't use them that way
Why would he leave the country ?
I think he's made it clear
Well, I think The Skeptics, Skeptics are falling short because, you know, they don't own up to
So I can say that since the Mayo Clinic finished their study in 2006, and it took them until 2013, to actually publish it, then I can say, well, Burzynski finished his in 2009, which was 3 years later, which would give Burzynski until 2016
for me to make up my mind
Well I can say, well I'm going to have to wait, the same amount of time I had to wait for Mayo to publish their study; which was from 2006 to 2013
How do you know it was delayed ?
I mean, has anybody
done a review of when a clinical trial is studied, and completed, and how long it took the people to publish it ?
You know
If they could point to me a study that's done that, and say, well here's the high end, here's the low end of the spectrum, here's the middle
Sure, but that's not gonna, you know like, answer an overall question of, you know, somebody did a comparative study of all clinical trials, and, when they were finished, and at, and when the study was actually published afterwards
You know, that's only gonna be one, particular clinical study
Well, we know that the Declaration of Helsinki doesn't even give a standard saying, "You must publish within x amount of years," you know ?
So, I've yet to find a Skeptic who posted something that said, "Here are the standards, published here"
Again, we get back to, when the clinical trial is finished, not when Burzynski started
I mean, you would expect to find a results to be published after, the final results are in
You would expect some people would want to have confidentiality, and maybe not want to be included
Why am I unsure ?
I just gave you an example
Oh, who said I was unsure ?
I just gave you an example
I mean, I'm just, I believe in free and open debate
I mean, I believe, if y'all are gonna spam the Internet, the Internet with garbage that y'all do not back-up, with specific
Like your tweet that said uh, "antineoplastons is uron, is Unicorn pee," right ?
"Burzynski is a vampire"
Good one
He sucks their blood out of 'em right ?
Okay, I understand humor
Well, that's because he's Polish
What I defend, is that, y'all post stuff, a lot of Skeptics post stuff, including Gorski, and they do not back it up, with references, citations, or links
Gorski will just post stuff, like he did about saying, you know, the FDA would not approve, uh, accelerated approval, without a final phase 2 clinical trial being published, which was an incorrect statement, he did not provide any link
We know it's false
Well, I'm just
I'm just
Well, that is just lame
Y'all, Skeptics, like to sh spam Twitter, and social media, with all this negative stuff about Burzynski, but then when I ask you to back it up, you can't back it up, and then, and then on this conversation you want to come down and pinhole it, to a specific subject, you know, the nitty-gritty
Well, if y'all were only debating the nitty-gritty, we would only be d debating the nitty-gritty, but that's not what y'all do
Well, we know the FDA's said there is
And I'll give you those links that I told you I would give you
Yeah, that's fine
Well, I thought it was productive too
You know, I don't see why Gorski is afraid of debating issues
on the Internet, on his blog
Hey, he has time to post about, "Hey, uh, Burzynski got a Catholic award from somebody," which, has nothing to do with antineoplastons, whatsoever
So, you know, he's not focusing just in on, "Do antineoplastons work, yes or no?," "When will Burzynski publish ?," yes or no ?
You know, he's putting all this ridiculous side junk, you know
So, I am not going to take that seriously
You bet
Thank you
You too
Thank you to the Didymus Judas Thomas Hipocritical Oath blog visitors
Thank you to the over 8,000 blog visitors
The United States of America
Albania – Falemnderit
Argentina – Gracias
Bosnia and Herzegovina
Brazil – Obrigado
Bulgaria – Благодаря Blagodarya
Chile – Gracias
Columbia – Gracias
Croatia – Hvala
Czech Republic – Děkuji
Denmark – Tak
Estonia – Aitäh
Finland – Kiitos
France – Merci
Germany – Danke
Greece – Σας ευχαριστώ Sas ef̱charistó̱
Guatemala – Gracias
Honduras – Gracias
Hong Kong
Hungary – Köszönöm
Iceland – Þakka þér
India – धन्यवाद Dhan'yavāda
Indonesia – Terima kasih
Ireland – Go raibh maith agat
Isle of Man
Israel – תודה אַ דאַנק 'a d'anq
Italy – Grazie
Japan – ありがとう Arigatō
Republic of Korea – 감사합니다 gamsahabnida
Latvia – Paldies
Lithuania – Ačiū
Malaysia – Terima kasih
Mexico – Gracias
Netherlands – Dank u
New Zealand
Norway – Takk
Peru – Gracias
Philippines – Gracias
Poland – Dziękuję
Portugal – Obrigado
Romania – Mulțumesc
Russian Federation – Спасибо Spasibo
Дзякуй Dziakuj
Serbia – Хвала Hvala
Slovenia – Hvala vam
South Africa – Dankie
Spain – Gracias
Sweden – Tack
Thailand – ขอบคุณ K̄hxbkhuṇ
Trinidad and Tobago
Turkey – Teşekkür ederim
Ukraine – Спасибі Spasybi
United Arab Emirates – شكرا
United Kingdom
Diolch yn fawr
Vietnam – Cảm ơn bạn


text:
Drop Dead Diva Sneak Peek: Jaleel White Haunts Jane's Dreams!
TV Guide
Urkel is back on TV - sort of!
On Sunday's Drop Dead Diva (9/8c, Lifetime) Jaleel White guest-stars as a game show host who haunts Jane's (Brooke Elliott) dreams. Suffice it to say, if you wouldn't want Urkel in your dreams, you certainly wouldn't want White's Bob tormenting you - especially if you're single. Check out an exclusive sneak peek at the episode:
Vote for your favorite new shows in our Fall TV Popularity Contest
Drop Dead Diva airs Sundays at 9/8c on Lifetime.
View original Drop Dead Diva Sneak Peek: Jaleel White Haunts Jane's Dreams! at TVGuide.com
Related Articles on TVGuide.com
Other Links From TVGuide.com


text:
Welcome! This website is about pots. And food. For me, these two things are inextricably linked. I make pots for eating and serving food. I make food to eat and serve out of pots. I love to feed people and I love to make pots for people.
The process of transformation is inherent to working with clay and to cooking. Ingredients are transformed by peeling, cutting and combining. Clay is transformed by shaping on the wheel, trimming, decorating, and glazing. The application of heat is important in the final transformation of clay to pottery and ingredient to finished dish. And when heat is in the form of fire itself, that transformation is especially dramatic.
As a potter, cook, mother, and psychologist, I am interested in creating and witnessing transformation. In making this site, I have tried to transform words and pictures into the story of my relationship with pots and with food.


text:
Hand Shakers
The anime takes place in Osaka in "AD20XX," and revolves around the Hand Shakers—partners who can summon "Nimrodes," weapons born from their deep psyche by joining hands. In order to grant the pair's wish, the Hand Shakers compete with and fight other Hand Shaker pairs. The top pair will then meet and challenge "God."
"They, the receivers of the Revelation of Babel. They, the challengers to God.
They, who inevitably throw themselves into battle with their partners. What does God want from them?
And did they want powers exceeding that of Gods? The chosen ones, their souls linked,
join hand and hand for the Ziggurat where the fighting shall ensue."
Please scroll down to choose servers and episodes.